Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;31(5):295–300. [Article in Spanish] doi: 10.1016/S0212-6567(03)79182-3

¿Existe relación entre la valoración del riesgo coronario según las tablas de Framingham y Sheffield con la del sexto informe del Joint National Committee? Relación entre tablas de riesgo coronario

Is there a relationship between the assessment of coronary risk on the framingham and sheffield tables and the sixth report of the joint national committee? relationship between tables of coronary risk

L Viñas Cabrera a, A Orti Llaveria b, C Aguilar Martín a,*, JM Pepió Villaubí a, V Rubio Carque a, M Miravalls Figuerola a
PMCID: PMC7679682  PMID: 12681144

Abstract

Objectives

To find the distribution of coronary risk (CR) in the various groups of hypertense patients in the Joint National Committee (JNC VI), using both the Framingham and Sheffield tables, and to assess whether there is a relationship between the different scales used.

Design

Descriptive study.

Setting

Tortosa Oeste Health District, Tarragona. Spain.

Participants

Rural population between 30 and 74 years old with Hypertension, but without any background of cardiovascular pathology.

Main measurements

The variables studied corresponded to the Anderson table in the Framingham study, the Sheffield table and the JNC VI one. Concordance was assessed with the kappa coefficient.

Results

148 hypertense patients with an average age of 62, 63.5% of whom were women, were studied. 23% had high CR on the Framingham, and 42.1% on the Sheffield. Distribution of the sample according to the stratification of the JNC VI was: A, 16.2%; B, 51.4%, and C, 32.4%. High risk on the Framingham in the various groups of the JNC VI was: A, 0%; B, 9.2%, and C, 56.3% (kappa, 0.533). High risk on the Sheffield in the groups of the JNC VI ran at: A, 4.2%; B, 41.3%, and C, 66.7% (kappa, 0.324).

Conclusions

There was moderate concordance between the Framingham tables and the JNC VI for calculation of CR in our population.

Key words: Hypertension, Coronary risk, Kappa-concordance

Bibliografía

  • 1.Villar Álvarez F., Maiques Galán A., Brotons Cuixart C., Torcal Laguna J., Lorenzo Piqueres A., Vilaseca Canals J. Del Grupo de Prevención Cardiovascular del PAPPS. Recomendaciones preventivas cardiovasculares: aplicaciones prácticas del riesgo cardiovascular. Aten Primaria. 1999;24(Supl 1):66–75. [PubMed] [Google Scholar]
  • 2.ackson R., Barham P., Bills J., Birch T., MCLennan L., MacMahon S. Management of raised blood pressure in New Zealand: a discussion document. BMJ. 1993;307:107–110. doi: 10.1136/bmj.307.6896.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Robson J., Boomla K., Hart B., Feder G. Estimating cardiovascular risk for primary prevention: oustanding questions for primary care. BMJ. 2000;320:702–704. doi: 10.1136/bmj.320.7236.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Anderson K.M., Wilson P.W.F., Odell P.M., Kanell W.B. Un update coronary risk profile. A statement for health professionals. Circulation. 1991;83:356–362. doi: 10.1161/01.cir.83.1.356. [DOI] [PubMed] [Google Scholar]
  • 5.Grupo de Trabajo de Prevención cardiovascular . Guía de prevención cardiovascular. Programa de Actividades Preventivas y de Promoción de la Salud. Sociedad Española de Medicina de Familia y Comunitaria. 1997. pp. 8–14. [Google Scholar]
  • 6.Sociedad Española de Medicina de Familia y Comunitaria . Programa de Actividades Preventivas y de Promoción de la Salud. Curso a distancia de Prevención en Atención Primaria. Renart; Barcelona: 1998. pp. 51–63. [Google Scholar]
  • 7.Zurro M., Gené J., Subías P. 4a ed. Vol. 26. Harcourt Brace; Madrid: 1999. pp. 469–499. (Actividades Preventivas y de promoción de la salud en el adulto. En: Atención Primaria conceptos, organización y práctica clínica,). [Google Scholar]
  • 8.Wood D., De Backe G., Faegerman O., Graham I., Mancia G., Pyörala K. Task Force Report. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Socieites on Coronary Prevention. Atherosclerosis. 1998;140:199–270. doi: 10.1016/s0021-9150(98)90209-x. [DOI] [PubMed] [Google Scholar]
  • 9.British Cardiac Society. British Hyperlipidaemia Association. British Hypertension Society. endorsed by the British Diabetic Association Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart. 1998;80(Suppl 2):1–29. [PMC free article] [PubMed] [Google Scholar]
  • 10.National Heart Fundation Clinical guidelines for the assesment and management of dislipidaemia. NZ Med J. 1996;190:224–232. [Google Scholar]
  • 11.Ramsay L., Haq I., Jackson P., Yeo W., Pickin D., Payne J. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet. 1996;348:387–388. doi: 10.1016/s0140-6736(96)05516-x. [DOI] [PubMed] [Google Scholar]
  • 12.World Health Organization-International society of hypertension 1999 World Health Organization-International society of hypertension Guidelines for the management of Hypertension. Guidelines subcommittee. J Hypertens. 1999;17:151–183. [PubMed] [Google Scholar]
  • 13.Haq I.U., Ramsay L.E., Yeo W.W., Jackson. Walis E.J. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart. 1999;81:40–46. doi: 10.1136/hrt.81.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ramachandran S., French J.M., Vanderpump M.P.J., Croft P., Neary R.H. Using The Framingham model to predict Heart disease in the United Kingdom: retrospective study. BMJ. 2000;320:676–677. doi: 10.1136/bmj.320.7236.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.West of Scotland Coronary Prevention Study Group Influence of Pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS) Circulation. 1998;97:1440–1445. doi: 10.1161/01.cir.97.15.1440. [DOI] [PubMed] [Google Scholar]
  • 16.Joint National Committee on Prevention. Detection. Evaluation. Treatment of High Blood Pressure The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–2446. doi: 10.1001/archinte.157.21.2413. [DOI] [PubMed] [Google Scholar]
  • 17.De la Figuera M. Aportacions novedoses en les recomanacions del VIè informe del JNC i OMS/SIH. Butlletí de la Societat Catalana de Medicina Familiar i Comunitària. 1999;76:8–9. [Google Scholar]
  • 18.Maiques A. Utilitat de la guia de prevenció cardiovascular per al maneig de la hipertensió arterial. Butlletí de la Societat Catalana de Medicina Familiar i Comunitària. 1999;76:9. [Google Scholar]
  • 19.Wallis E.J., Ramsay L.E., Haq I.U., Ghahramani P., Jackson P.R., Rowland-Yeo K. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. BMJ. 2000;320:671–675. doi: 10.1136/bmj.320.7236.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.American Diabetes Association Report of the expert committee on the diagnosis and clasification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197. doi: 10.2337/diacare.20.7.1183. [DOI] [PubMed] [Google Scholar]
  • 21.Pÿorälä K., Backer G., Poole-Wilson P., Wood D. The European Society of Cardiology: Prevention of coronary heart disease in clinical practice. Eur Heart J. 1994;15:1300–1331. doi: 10.1093/oxfordjournals.eurheartj.a060388. [DOI] [PubMed] [Google Scholar]
  • 22.Maiques A., Brotons C., Villar F., Aleixendre M.E., Banegas J.R., Forés D. Guía de prevención cardiovascular. Sersa; Madrid: 1996. [Google Scholar]
  • 23.Villar F., Banegas J.R., Rodríguez F., Rey J. Mortalidad cardiovascular en España y sus comunidades autónomas (1975–1992) Med Clin (Barc) 1998;110:321–327. [PubMed] [Google Scholar]
  • 24.Argimon Pallás J.M., Jiménez Villa J. Análisis de la concordancia. In: Argimón Pallás J.M., Jiménez Villa J., editors. Métodos de investigación clínica y epidemiológica. Harcourt Brace; Madrid: 1999. pp. 321–325. [Google Scholar]
  • 25.Maiques Galan A., Vilaseca Canals J. Variabilidad en la valoración del riesgo cardiovascular. FMC. 2000;7:611–628. [Google Scholar]
  • 26.Donald M., Jones L.L., Jane C., Martin G., Larson M.G., O’Don-nell C.J. Cross-classification of JNC VI Blood Pressure Stages and Risk Groups in the Framingham Heart Study. Arch Intern Med. 1999;159:2206–2212. doi: 10.1001/archinte.159.18.2206. [DOI] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES